EHC 2022
ProgrammePostersPeople
Search
  • EN
All people

Christopher M. Jensen

Type

Engagements

09 Dec

  • 15:30 – 15:35 3 Min. 2 Min.
    • ePoster
    • P115
    Rimegepant for the Acute Treatment of Migraine: Subgroup Analyses From 3 Phase 3 Clinical Trials by Triptan Treatment Experience
     CGRP inhibitors in the clinic, Migraine
  • 15:40 – 15:45 3 Min. 2 Min.
    • ePoster
    • P122
    Oral Rimegepant 75 mg is Safe and Well Tolerated in Adults With Migraine and Cardiovascular Risk Factors: Results of a Multicenter, Long-Term, Open-Label Safety Study
     CGRP inhibitors in the clinic, Migraine
  • 15:45 – 15:50 3 Min. 2 Min.
    • ePoster
    • P123
    Medication Preference, Satisfaction, and Clinical Improvement Among Adults Receiving Long-Term Treatment With Rimegepant for Migraine
     CGRP inhibitors in the clinic, Migraine
    • v1.25.2
    • © Conventus Congressmanagement & Marketing GmbH
    • Imprint
    • Privacy

Cookie settings

We use cookies on our website. Cookies are small (text) files that are created and stored on your device (e.g., smartphone, notebook, tablet, PC). Some of these cookies are technically necessary to operate the website, other cookies are used to extend the functionality of the website or for marketing purposes. Apart from the technically necessary cookies, you are free to allow or not allow cookies when visiting our website.

Imprint | Privacy